CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 10 of 14

Lupus

Briefs 361–400 of 555 CurrentRheuma has covered from this journal, newest publication first

Latest from Lupus

All coverage, newest first

  1. Lupus

    The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study

    Cohort studyLupus & APS

  2. Lupus

    Epidemiological, immunological, and treatment response profile of patients with lupus nephritis in Brazil

    Cohort studyLupus & APS

  3. Lupus

    Significant heightened methylation levels of RUNX3 gene promoter in patients with systemic lupus erythematosus

    Case-control studyLupus & APS

  4. Lupus

    Initiation of belimumab with higher daily prednisolone is effective for rapid glucocorticoid reduction: A 96-week retrospective study

    Cohort studyLupus & APS

  5. Lupus

    Aberrant phenotypes of circulating γδ-T cells may be involved in the onset of systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  6. Lupus

    ANCA in patients with systemic lupus erythematosus. A cross sectional study in Brazilian patients and review of literature

    Cross-sectional studyLupus & APS

  7. Lupus

    Global tuberculosis disease and infection in systemic lupus erythematosus patients: A systematic review and meta-analysis

    Meta-analysisLupus & APS

  8. Lupus

    Glucocorticoid-free remission in patients with SLE in the era of biologics: Immune complex disease is likely to benefit from current medications

    Cohort studyLupus & APS

  9. Lupus

    Childhood adverse experiences and clinical manifestations in women with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  10. Lupus

    Using combination of albumin to fibrinogen ratio and prognostic nutritional index model for predicting disease activity in patients with systemic lupus erythematosus

    Diagnostic or prognostic studyLupus & APS

  11. Lupus

    Comparison of late-onset and non-late-onset systemic lupus erythematosus individuals in a real-world electronic health record cohort

    Cohort studyLupus & APS

  12. Lupus

    Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice

    Cohort studyLupus & APS

  13. Lupus

    Comparison of the SLE Risk Probability Index (SLERPI) scale against the European League Against Rheumatism/American College of Rheumatology (ACR/EULAR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria

    Cohort studyLupus & APS

  14. Lupus

    Positive psychological capital, post-traumatic growth, social support, and quality of life in patients with systemic lupus erythematosus: A cross-sectional study

    Cross-sectional studyLupus & APS

  15. Lupus

    Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019

    Cohort studyLupus & APS

  16. Lupus

    Impact of preeclampsia on infant and maternal health among women with rheumatic diseases

    Cohort studyLupus & APS

  17. Lupus

    Genetically predicted circulating interleukin-18 levels are associated with risk of systemic lupus erythematosus and type 1 diabetes

    Research articleLupus & APS

  18. Lupus

    Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus

    Cohort studyPediatric

  19. Lupus

    Granulin in renal tubular epithelia is associated with interstitial inflammation and activates the TLR9-IFN-α pathway in lupus nephritis

    Mechanistic studyLupus & APS

  20. Lupus

    Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort

    Cohort studyLupus & APS

  21. Lupus

    Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review

    Research articleLupus & APS

  22. Lupus

    Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score

    Cohort studyLupus & APS

  23. Lupus

    Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China

    Cohort studyLupus & APS

  24. Lupus

    Correlation between the changes of brain amplitude of low-frequency fluctuation and cognitive impairment in patients with neuropsychiatric lupus

    Cross-sectional studyLupus & APS

  25. Lupus

    Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients

    Cohort studyLupus & APS

  26. Lupus

    A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2

    Cohort studyLupus & APS

  27. Lupus

    The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus

    Research articleLupus & APS

  28. Lupus

    Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis

    Cohort studyLupus & APS

  29. Lupus

    Rhupus syndrome in children: A multi-center retrospective cohort study and literature review

    Cohort studyPediatric

  30. Lupus

    The potential causal association between systemic lupus erythematosus and endocrine and metabolic disorders in the East Asian population: A bidirectional two-sample Mendelian randomization study

    Research articleLupus & APS

  31. Lupus

    Lupus nephritis and socioeconomic status: Findings from the Southern California lupus registry

    Cohort studyLupus & APS

  32. Lupus

    Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays

    Cohort studyLupus & APS

  33. Lupus

    Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis

    Cohort studyLupus & APS

  34. Lupus

    The effect of respiratory muscle training on respiratory muscle strength, diaphragm thickness/mobility, and exercise capacity in patients with systemic lupus erythematosus and associated shrinking lung syndrome

    Cohort studyLupus & APS

  35. Lupus

    Clinical algorithm model based on cfDNA to predict SLE disease activity

    Cross-sectional studyLupus & APS

  36. Lupus

    Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients

    Cohort studyLupus & APS

  37. Lupus

    A qualitative study of facilitators of medication adherence in systemic lupus erythematosus: Perspectives from rheumatology providers/staff and patients

    Research articleLupus & APS

  38. Lupus

    The clinicopathological features and renal prognostic factors in pure membranous lupus nephritis—a large series cohort study from China

    Cohort studyLupus & APS

  39. Lupus

    Changes in retinal and choroidal thickness and vascular density in patients with systemic lupus erythematosus: Assessed by optical coherence tomography angiography

    Cross-sectional studyLupus & APS

  40. Lupus

    Non-invasive prediction of the chronic degree of lupus nephropathy based on ultrasound radiomics

    Diagnostic or prognostic studyLupus & APS

All 555 Briefs in ExploreShowing Briefs 361–400 of 555, newest first